Bionic Eye in View of U.S. Market
The device, called the Argus II and developed by Los Angeles-based medical device company Second Sight Medical Products, is already available in Europe. It implants electrodes in the retina of visually-impaired persons suffering from retinitis pigmentosa or macular degeneration, and uses video-capturing glasses to send images to the brain.
Second Sight has spent $200 million developing the product, half of which came from investors and the rest through federal grants.
More Articles on Medical Devices:Zimmer's 4Q Profits Drop 2.4% to $153M
Medical Device Tax Gathers $97M From Revenue in January
Sightpath Medical to Mobilize Femtosecond Laser for Cataract Surgery
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- Middle Tennessee School of Anesthesia works to decrease opioid usage: 3 notes
- FDA clears Pure-Vu System for intra-procedural colon cleaning: 3 notes
- FDA approves STELARA for Crohn's disease treatment: 5 notes
- AGA objects to American Board of Internal Medicine's certification proposals: 4 notes
- Dr. Simon Rabinowitz named a Who's Who by Marquis: 5 takeaways